B2M and central nervous system leukemia: In the CNSL group, the median CSF β2-M level was 3.0 (range, 1.2–13.5) mg/L, significantly higher than other groups (p < 0.001 for CNS leukemia, CNS solid tumor, and CNS miscellaneous diseases; p = 0.095 for CNS infectious diseases).